ROY F CHEMALY to Palivizumab
This is a "connection" page, showing publications ROY F CHEMALY has written about Palivizumab.
Connection Strength
0.697
-
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018 03 28; 217(8):1247-1256.
Score: 0.158
-
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
Score: 0.146
-
Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol. 2014 Aug; 36(6):e376-81.
Score: 0.123
-
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011 Mar 10; 117(10):2755-63.
Score: 0.095
-
Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
Score: 0.091
-
Palivizumab: where to from here? Expert Opin Biol Ther. 2009 Jan; 9(1):139-47.
Score: 0.084